CHRU Nantes

Nantes 602 00

0 studies enrolling now · 5 studies all time

What they study most

Acute Myeloid Leukemia (AML), Anemia, Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia (CMML), Influenza, Low to Intermediate-1 MDS, Multiple Myeloma, Myelodysplastic Syndromes, Myelodysplastic Syndromes (MDS), Ulcerative Colitis

Studies at this site

• A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy — Completed
• Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML) — Completed
• Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza — Completed
• Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis — Completed
• A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and Refractory Multiple Myeloma and Companion Study — Completed